secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0000950170-25-086256
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Olema shareholders elect three Class II directors, approve say-on-pay, ratify EY
--------------------------------------------------------------------------------

- Cynthia Butitta: 44,675,129 for, 11,733,848 withheld; Cyrus Harmon: 43,838,514 for, 12,570,463 withheld; Graham Walmsley: 44,120,432 for, 12,288,545 withheld.
- Advisory vote on executive compensation: 54,057,177 for, 2,297,482 against, 54,317 abstain; broker non-votes 6,361,695.
- Ratification of Ernst & Young as auditor: 62,732,079 for, 24,064 against, 14,528 abstain; no broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000095017025086256/0000950170-25-086256-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000095017025086256/olma-20250610.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-086256

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer